Huyut, Mehmet Tahir; Kocatürk, İdris

The authors would like to acknowledge the oversight in omitting the ethical approval number in the article titled “The Effect of Some Symptoms and Features During the Infection Period on the Level of Anxiety and Depression of Adults after Recovery from COVID-19” published in Current Psychiatry Research and Reviews, 2022, 18(2), pp: 161 [1]. Details of the error and a correction are provided here. ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study protocol was approved by the Institutional Ethics Review Board of Erzincan Binali Yıldırım University after being approved by the Ministry of Health of the Republic of Turkey. HUMAN AND ANIMAL RIGHTS: No animals were used in this study. The procedure of the human experiments is in accordance with the Declaration of the Helsinki World Medical Association. ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by the Erzincan Binali Yıldırım University Human Research Health and Sports Sciences Ethics Committee (20/10/2021, Protocol No: 08-03) and the Ministry of Health of the Republic of Turkey. HUMAN AND ANIMAL RIGHTS: The reported experiments on humans were in accordance with the ethical standards of the committee responsible for human experimentation (institutional national), and with the Helsinki Declaration of 1989. We regret the error and apologize to readers. The original article can be found online at https://www.eurekaselect.com/article/121872

Huyut, Mehmet Tahir; Kocatürk, İdris

Background: Considering the previous evidence regarding SARS/MERS outbreaks, ıt is expected that emergent psychiatric conditions such as mood disorders, anxiety, and depression disorders may occur in survivors of COVID-19. Objectives: In this study, the effects of clinical/neurological symptoms and sociodemographic characteristics of COVID-19 patients during the infection period on the level of anxiety/depression after recovery were investigated. Methods: Firstly, the socio-demographic characteristics of the participants and their clinical/neurological symptoms during the infection period were determined. In addition, the Beck anxiety/depression scale was administered to the participants upon discharge. Then, the odds ratio of the variables was calculated by applying the Poisson regression method to determine the predictors affecting the level of anxiety/depression. Results: In this study, the clinical/neurological symptoms and the sociodemographic characteristics affecting the level of anxiety/depression were found to be associated with adults (mean age 45-years). The number of days of hospitalization was the only clinical feature that increased both anxiety and depression levels. In addition, post-discharge sleep disorder, headache, and alcohol use were found to be predictors of increased anxiety levels. In addition, smoking, the presence of a person with COVID-19 infection in the immediate vicinity, traveling in the last month before the illness, fever, and loss of smell during the infection period was found to increase the level of depression. Moreover, asthma was the only significant comorbidity that increased the anxiety level, while diabetes was the only comorbidity that increased the depression level. Conclusion: It is expected that this study will support social-psychological intervention and have some effects on reducing depressive/anxiety symptoms, which can vary widely in adults during stressful events.